![]() Aravive Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies. | ![]() MaxiVAX MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. | ![]() Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. | ![]() ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. | |
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Private | Type Public | Type Public |
Tags | ||||
Locations | Locations Houston, US HQ | Locations Genève, CH HQ Genève, CH | Locations Lexington, US HQ Lexington, US | Locations Epalinges, CH HQ London, GB New Providence, US |
Employees | Employees 23 | Employees 5 | Employees 3144% decrease | Employees 1162% increase |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) N/A | Valuation ($) 29.4 m | Valuation ($) 295.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $9.1m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $9.4m (FY, 2025) | Revenue (est.) $81.4m (FY, 2025) |
Net income | Net income ($76.3m) (FY, 2022) | Net income N/A | Net income ($7.6m) (FY, 2025) | Net income ($142.6m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 8.1m | Total funding raised N/A | Total funding raised $ 526m |

MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
View company
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View company
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
View company